Logo image of MUX

MCEWEN INC (MUX) Stock Fundamental Analysis

NYSE:MUX - New York Stock Exchange, Inc. - US58039P3055 - Common Stock - Currency: USD

11.33  +0.38 (+3.47%)

After market: 11.33 0 (0%)

Fundamental Rating

3

Taking everything into account, MUX scores 3 out of 10 in our fundamental rating. MUX was compared to 154 industry peers in the Metals & Mining industry. MUX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, MUX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MUX has reported negative net income.
In the past year MUX had a positive cash flow from operations.
In the past 5 years MUX reported 4 times negative net income.
In the past 5 years MUX reported 4 times negative operating cash flow.
MUX Yearly Net Income VS EBIT VS OCF VS FCFMUX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -4.05%, MUX is not doing good in the industry: 60.39% of the companies in the same industry are doing better.
With a Return On Equity value of -6.16%, MUX perfoms like the industry average, outperforming 43.51% of the companies in the same industry.
Industry RankSector Rank
ROA -4.05%
ROE -6.16%
ROIC N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
MUX Yearly ROA, ROE, ROICMUX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

MUX has a Gross Margin (20.71%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MUX has grown nicely.
The Profit Margin and Operating Margin are not available for MUX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
MUX Yearly Profit, Operating, Gross MarginsMUX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MUX has been increased compared to 1 year ago.
Compared to 5 years ago, MUX has more shares outstanding
MUX has a better debt/assets ratio than last year.
MUX Yearly Shares OutstandingMUX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MUX Yearly Total Debt VS Total AssetsMUX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MUX has an Altman-Z score of -0.81. This is a bad value and indicates that MUX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.81, MUX is not doing good in the industry: 87.66% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.26 indicates that MUX is not too dependend on debt financing.
MUX has a worse Debt to Equity ratio (0.26) than 60.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -0.81
ROIC/WACCN/A
WACC9.05%
MUX Yearly LT Debt VS Equity VS FCFMUX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MUX has a Current Ratio of 2.35. This indicates that MUX is financially healthy and has no problem in meeting its short term obligations.
MUX has a Current ratio of 2.35. This is comparable to the rest of the industry: MUX outperforms 52.60% of its industry peers.
MUX has a Quick Ratio of 1.89. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
MUX has a Quick ratio (1.89) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 1.89
MUX Yearly Current Assets VS Current LiabilitesMUX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

MUX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.08%, which is quite impressive.
Looking at the last year, MUX shows a decrease in Revenue. The Revenue has decreased by -2.18% in the last year.
MUX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.32% yearly.
EPS 1Y (TTM)52.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-13.42%

3.2 Future

The Earnings Per Share is expected to grow by 73.18% on average over the next years. This is a very strong growth
Based on estimates for the next years, MUX will show a very strong growth in Revenue. The Revenue will grow by 86.64% on average per year.
EPS Next Y113.44%
EPS Next 2Y73.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.92%
Revenue Next 2Y-6.97%
Revenue Next 3Y86.64%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MUX Yearly Revenue VS EstimatesMUX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MUX Yearly EPS VS EstimatesMUX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 -2 -3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MUX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 18.29, MUX is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MUX is on the same level as its industry peers.
MUX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.44.
Industry RankSector Rank
PE N/A
Fwd PE 18.29
MUX Price Earnings VS Forward Price EarningsMUX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MUX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.66
MUX Per share dataMUX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MUX's earnings are expected to grow with 73.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.18%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MUX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MCEWEN INC

NYSE:MUX (7/21/2025, 7:01:39 PM)

After market: 11.33 0 (0%)

11.33

+0.38 (+3.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners40.58%
Inst Owner Change-0.03%
Ins Owners0.46%
Ins Owner Change0.06%
Market Cap611.71M
Analysts80
Price Target15.36 (35.57%)
Short Float %10.74%
Short Ratio6.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100.17%
Min EPS beat(2)-197.03%
Max EPS beat(2)-3.31%
EPS beat(4)1
Avg EPS beat(4)-47.52%
Min EPS beat(4)-197.03%
Max EPS beat(4)64%
EPS beat(8)4
Avg EPS beat(8)-30.3%
EPS beat(12)5
Avg EPS beat(12)-77.69%
EPS beat(16)6
Avg EPS beat(16)-127.74%
Revenue beat(2)1
Avg Revenue beat(2)-3.21%
Min Revenue beat(2)-9.51%
Max Revenue beat(2)3.09%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)7.08%
Revenue beat(8)6
Avg Revenue beat(8)1.12%
Revenue beat(12)6
Avg Revenue beat(12)-4.27%
Revenue beat(16)7
Avg Revenue beat(16)-3.95%
PT rev (1m)5.24%
PT rev (3m)3.43%
EPS NQ rev (1m)200%
EPS NQ rev (3m)114.29%
EPS NY rev (1m)265%
EPS NY rev (3m)131.73%
Revenue NQ rev (1m)3.37%
Revenue NQ rev (3m)17.63%
Revenue NY rev (1m)8.38%
Revenue NY rev (3m)-21.93%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.29
P/S 3.62
P/FCF N/A
P/OCF 25.87
P/B 1.27
P/tB 1.27
EV/EBITDA 27.66
EPS(TTM)-0.69
EYN/A
EPS(NY)0.62
Fwd EY5.47%
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)0.44
OCFY3.86%
SpS3.13
BVpS8.89
TBVpS8.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.05%
ROE -6.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.71%
FCFM N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 5.54
Cap/Depr 183.98%
Cap/Sales 32.23%
Interest Coverage N/A
Cash Conversion 104.34%
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 1.89
Altman-Z -0.81
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)153.99%
Cap/Depr(5y)131.29%
Cap/Sales(3y)27.62%
Cap/Sales(5y)24.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
EPS Next Y113.44%
EPS Next 2Y73.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-13.42%
Revenue Next Year-12.92%
Revenue Next 2Y-6.97%
Revenue Next 3Y86.64%
Revenue Next 5YN/A
EBIT growth 1Y90.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.02%
OCF growth 3YN/A
OCF growth 5YN/A